Moving towards a precision approach for prevention of severe COVID-19

Affiliations

¹ VA Boston Healthcare System, Harvard Medical School, Boston, MA 02130, USA.
² VA Boston Healthcare System, Harvard Medical School, Boston, MA 02130, USA. Electronic address: paul.monach@va.gov.

Comment

Westyn Branch-Elliman et al. Lancet. 2023.

. 2023 Apr 29;401(10386):1423-1424.

doi: 10.1016/S0140-6736(23)00443-9.

¹ VA Boston Healthcare System, Harvard Medical School, Boston, MA 02130, USA.
² VA Boston Healthcare System, Harvard Medical School, Boston, MA 02130, USA. Electronic address: paul.monach@va.gov.

No abstract available

Comment in

Moving towards a precision approach for prevention of severe COVID-19 - Authors' reply.
Agrawal U, Robertson C, Sheikh A. Agrawal U, et al. Lancet. 2023 Apr 29;401(10386):1424. doi: 10.1016/S0140-6736(23)00444-0. Lancet. 2023. PMID: 37120282 Free PMC article. No abstract available.

Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales.
Agrawal U, Bedston S, McCowan C, Oke J, Patterson L, Robertson C, Akbari A, Azcoaga-Lorenzo A, Bradley DT, Fagbamigbe AF, Grange Z, Hall ECR, Joy M, Katikireddi SV, Kerr S, Ritchie L, Murphy S, Owen RK, Rudan I, Shah SA, Simpson CR, Torabi F, Tsang RSM, de Lusignan S, Lyons RA, O'Reilly D, Sheikh A. Agrawal U, et al. Lancet. 2022 Oct 15;400(10360):1305-1320. doi: 10.1016/S0140-6736(22)01656-7. Lancet. 2022. PMID: 36244382 Free PMC article.

1. Agrawal U, Bedston S, McCowan C, et al. Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales. Lancet. 2022;400:1305–1320. - PMC - PubMed
1. Vo AD, La J, Wu JT, et al. Factors associated with severe COVID-19 among vaccinated adults treated in US Veterans Affairs hospitals. JAMA Netw Open. 2022;5 - PMC - PubMed
1. Monach P, Branch-Elliman W. From pandemic to endemic. February, 2022. https://www.contagionlive.com/view/from-pandemic-to-endemic
1. Focosi D, McConnell S, Casadevall A. The omicron variant of concern: diversification and convergent evolution in spike protein, and escape from anti-spike monoclonal antibodies. Drug Resist Updat. 2022;65 - PMC - PubMed